FrançaisMovember

In The News

PSA Fitness (Power, Strength & Agility)
HALIFAX, N.S., January 16, 2012/CNW/ Prostate Cancer Canada Atlantic is proud to announce the launch of PSA Fitness (Power, Strength & Agility), a free nine week exercise program for men who have been diagnosed with prostate cancer.  PSA Fitness, resistance training and yoga, is an important patient-centered therapy for prostate cancer survivors in Halifax.

TELUS donation to support Prostate Cancer Canada
Toronto, ON- January 13, 2012- On January 10th, Prostate Cancer Canada received a generous donation of $100,000 from TELUS at the launch of the TIEd Together exhibition. TELUS’ donation was made possible through the Canadian Football League Grey Cup cause marketing campaign. The donation will support Prostate Cancer Canada’s ongoing efforts to eliminate the disease through research, education, support and awareness.

Click For Information Archive
Print this page.  Bookmark this page. Decrease font size.Increase font size.



Missing gene makes prostate cancer more aggressive

2/24/2010

Research suggests that prostate cancer is more likely to spread and become more aggressive if a specific gene known as DAB2IP quits functioning.
 
 

New research gathered from researcher at UT Southwestern Medical Center suggests that prostate cancer is more likely to spread and become more aggressive if a specific gene known as DAB2IP quits functioning.

Studies have found that various prostate cancer cells can be held in check by the DAB2IP cell, and that when this gene is involved, it prevents other proteins that are present in the development of prostate cancer from becoming over-active.

When the DAB2IP gene stops functioning normally and cells lose this gene, they are able to break free and begin to metastasize and spread to other areas of the body, thus increasing the risk that the cancer will spread to other areas of the body – other organs, lymph system and/or bloodstream.

The study which was published in the Proceedings of the National Academy of Sciences, found that when DAB2IP was eliminated from human carcinoma cells it caused them to change to mesenchymal cells – a sign of metastatic cancer. Cells that have undergone this change have the ability to move easily throughout the body – when the gene is restored it seems as though it reverses the ability to metastasize. Researchers believe that by identifying this gene it can act as a bio-marker aiding physicians in identifying patients with aggressive prostate cancer.

View a complete abstract of this article in
Proceedings of the National Academy of Science.

 
 
Thanks for the follows! @RabyInstitute @THENUMBERUNEO @BBSupport @JackieManthorne @TELUS @ABJuniorCurling @PatientStories1 @healthfinder
Follow Us On Twitter
Prostate Cancer Canada
2 Lombard Street, 3rd Floor, Toronto
Ontario M5C 1M1, Canada
info@prostatecancer.ca

Telephone: 416-441-2131
Toll-free: 1-888-255-0333
Fax: 416-441-2325
© 2011 - Prostate Cancer Canada - Charitable Registration Number: BN 89127 0944 RR0001
Design and Development Inorbital